The E.U.’s pharma overhaul, Lilly’s booming business, & a long-awaited drug approval

Who sent Meg a Cameo?

April 28, 2023 Check out STAT+

Sponsored By

Is a specter haunting Europe? Will Eli Lilly usurp Johnson & Johnson? And what does "Vowst" call to mind? We cover all that and more this week on "The Readout LOUD," STAT's biotech podcast. Andrew Joseph, STAT's Europe correspondent, joins us to explain the EU's sweeping proposal to overhaul how new drugs are regulated on the continent — and why the pharmaceutical industry is fighting it. We also discuss the latest news in the life sciences, including Lilly's surging business, a pair of new drug approvals, and a novel idea in Alzheimer's disease. Listen Now Subscribe to the podcast to never miss an episode iTunes Spotify SoundCloud Stitcher TuneIn YouTube Visit the archive to see past episodes

---

---

Enjoying The Readout LOUD? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser